Webinar
Strawberry Creek Ventures Masterclass Live
Join Alumni Ventures’ Matt Caspari and Carl Choi for an exclusive Masterclass webinar hosted by Strawberry Creek Ventures.
This session will unpack how our team evaluates venture opportunities, from sourcing deals and conducting diligence to ultimately saying yes to an investment. You’ll hear firsthand how we identify emerging technology trends and assess founder-market fit, business model scalability, and exit potential.
Whether you’re new to venture capital or looking to deepen your understanding of the investment process, this conversation will offer actionable insights and real-world case studies. This is a great opportunity to learn how our investment team builds a strong, diversified portfolio with exposure to some of the most promising startups in the market. Reserve your spot today to gain a deeper understanding of the venture evaluation process from two seasoned investors.
Want to access our Strawberry Creek Venture’s Syndicate startup deals to see, evaluate, and optionally invest? No cost, no commitment.
Why Attend?
- HomeUnderstand how venture capitalists evaluate early-stage startups and make investment decisions
- HomeLearn how Alumni Ventures’ investment process balances risk, opportunity, and portfolio fit
- HomeHear real-world examples of deals from the Strawberry Creek Ventures portfolio
Alumni Ventures is America’s largest venture capital firm for individual investors.
About your presenters
Overview
Matt Caspari invests in mission-driven founders building the next generation of iconic companies—entrepreneurs tackling the world’s hardest, highest-stakes problems. He backs breakthrough technologies with the potential to redefine critical industries, unlock new markets, and create a more sustainable, secure future.
Before Alumni Ventures, Matt was a two-time venture-backed founder/CEO and a leader of the innovation team at Nike. He founded Aurora Biofuels, a deep-tech venture that grew to 100+ employees and secured more than $100 million in funding before its acquisition by Reliance Industries. Earlier, he advised life science multinationals at Cambridge Pharma Consultancy (acquired by IMS Health) and gained experience on Bloomberg’s M&A team. Matt holds a BS in Biochemistry from Georgetown University and an MBA with a Certificate in Entrepreneurship from UC Berkeley.
Funds actively worked on
Investment Area of Focus
His investment lens favors bold solutions to global challenges and durable advantages rooted in technology and aligned with long-term megatrends. This translates to surgical robots powered by physical AI, next-generation energy systems, space-based infrastructure, longevity therapeutics, and more. The through-line is the potential for extraordinary value creation at the intersection of deep science and global need.
Representative investments Matt has led for Alumni Ventures include Andromeda Surgical and Cytronic (Physical AI); Arda Therapeutics and Cambrian Biopharma (Technologies for the Human Body); Max Space and Orbital Operations (Space Infrastructure); and Fortera and Mainspring Energy (The New Energy Stack). Alumni Ventures’ Deep Tech portfolio also includes companies such as Axiom Space, Ayar Labs, Cohere, Frore Systems, Groq, Hawkeye360, Hayden AI, Lambda, Radiant, and Rigetti (Nasdaq: RGTI).
Learn How To Invest In Companies In This Sector With Alumni Ventures:
Deep Tech Fund>>>
Overview:
Carl brings a systems-level mindset to venture investing, shaped by two decades of experience across public equities, M&A, and technology. He focuses on foundational technologies that rewire how the real world operates—betting on enduring platforms across deep tech sectors such as climate, energy, infrastructure, space, and AI. His work is rooted in a belief that innovation at the intersection of the physical and digital worlds is key to building a more equitable and sustainable future.
Funds actively worked on:
Strawberry Creek Ventures
Investment Areas of Focus:
At Alumni Ventures, Carl backs companies with the potential to tilt markets and drive systemic change. He gravitates toward mission-driven founders with deep technical insight — those unlocking new layers of productivity, resilience, and sustainability while reshaping legacy systems. His thesis centers on platform technologies with long time horizons and compounding strategic advantages — businesses that scale with time and fundamentally transform how industries operate.
Recent investments that reflect this approach include:
- 44.01, permanently removing CO₂ through mineralization in peridotite formations
- Omnidian, providing performance assurance for distributed solar assets
- Equilibrium Energy, building software-defined power markets
- Pebble, creating all-electric smart trailers for off-grid living
- Navier, designing hydrofoiling electric watercraft
- Neo Financial, reimagining consumer finance in Canada
- Radix Health, improving out-of-network reimbursement for healthcare providers
- Cerby, securing unmanageable apps in modern enterprises
- LeoLabs, operating radar infrastructure for orbital tracking
- Samaya AI, deploying expert AI agents in financial services
Prior to Alumni Ventures, Carl was a Principal at Solasta Ventures, where he led investments in deep tech and enterprise software. He previously held corporate development and strategy roles at Upwork and Riverbed Technology, and began his finance career at London Capital Management before moving into investment banking at J.P. Morgan in San Francisco.
Hailing from Korea and Canada, Carl holds a double degree in Mathematics and Business Administration from the University of Waterloo and Wilfrid Laurier University, and an MBA from UC Berkeley Haas. Outside of work, he enjoys spirited competition on the soccer field, at the poker table, or over hours-long board games.